Indication
Vaccine-Preventable Diseases
10 clinical trials
17 products
1 drug
Clinical trial
A Randomized, Open-labelled, Parallel, Phase 1 Clinical Study to Evaluate the Safety, Reactogenicity and Immunogenicity of the Hepatitis B Vaccine CVI-HBV-002 in AdultsStatus: Completed, Estimated PCD: 2023-09-25
Product
CVI-HBV-002Clinical trial
Phase 2, Randomized, Active-Controlled, Observer-Blinded, Multicenter Trial of the Immunogenicity, Safety, and Tolerability of rF1V Vaccine With CpG 1018® Adjuvant Compared With rF1V Vaccine in Adults 18 to 55 Years of AgeStatus: Active (not recruiting), Estimated PCD: 2023-10-03
Product
rF1VProduct
rF1V vaccineProduct
CVI-VZV-001Clinical trial
A Multicenter, Active-controlled, Open-label Phase I Study to Assess Safety and Tolerability and to Explore Immunogenicity of CVI-VZV-001 Vaccine in Healthy Adults Aged 50 to 64 YearsStatus: Recruiting, Estimated PCD: 2025-03-21
Product
ShingrixProduct
Z-1018Clinical trial
A Phase 1 Randomized, Subject-Blinded, Active-Controlled, Dose Escalation, Multicenter Trial to Evaluate the Safety, Tolerability, and Immunogenicity of an Investigational Herpes Zoster Vaccine (Z-1018) Compared to Shingrix® in Healthy Adult Volunteers Between the Ages of 50 and 69 YearsStatus: Completed, Estimated PCD: 2022-10-20
Clinical trial
Booster Epidemiological Evaluation of Health, Illness and Vaccine Efficacy Study: Randomized Trial to Compare the Clinical Efficacy of Novavax vs. mRNA COVID-19 2023-2024 Updated Vaccines Among Adults 18-49 and 50+ Years in the United StatesStatus: Recruiting, Estimated PCD: 2024-07-30
Product
Novavax COVID-19 vaccineProduct
Pfizer COVID-19 mRNA vaccineClinical trial
Optimisation of Lymph Node Fine Needle Aspiration to Study Pneumococcal Vaccine-induced ImmunityStatus: Recruiting, Estimated PCD: 2024-10-15
Product
Pneumococcal VaccineClinical trial
Comparison of Immunogenicity and Safety of Inactivated and Live-attenuated Hepatitis A Virus Vaccine Among Thai Healthy Children and Adolescents: A Randomized, Active-controlled, Open-label, Non-inferiority TrialStatus: Not yet recruiting, Estimated PCD: 2025-03-01
Product
Mevac-AProduct
Havrix 720 JuniorClinical trial
Immune Response Elicited by Concomitant Administration of Oral Typhoid Fever (Vivotif®) and Cholera (Dukoral®) VaccinesStatus: Recruiting, Estimated PCD: 2025-12-01
Product
Oral typhoid fever vaccineProduct
Oral cholera vaccineClinical trial
A Multicenter, Randomized, Double-blind, Placebo-controlled Phase III Clinical Trial to Evaluate the Protective Efficacy, Safety, and Immunogenicity of Recombinant Herpes Zoster Vaccine (CHO Cells) in Subjects Aged 40 Years and OlderStatus: Recruiting, Estimated PCD: 2024-12-31
Clinical trial
A Randomized, Double-blind, Placebo-controlled Phase I Clinical Study to Evaluate Safety and Tolerability of a Recombinant Herpes Zoster Vaccine (LZ901) in Subjects Aged 50 to 70 Years InclusiveStatus: Recruiting, Estimated PCD: 2024-02-01
Drug
Varlilumab